156 related articles for article (PubMed ID: 31966510)
1. MicroRNA-146a regulates cisplatin-resistance of non-small cell lung cancer cells by targeting NF-κB pathway.
Jiang P; Jia W; Wei X; Zhang X; Wang C; Li B; Song T; Yang J; Zhu D; Meng Y
Int J Clin Exp Pathol; 2017; 10(12):11545-11553. PubMed ID: 31966510
[TBL] [Abstract][Full Text] [Related]
2. miR-146a promotes Borna disease virus 1 replication through IRAK1/TRAF6/NF-κB signaling pathway.
Zhang X; Guo Y; Xu X; Tang T; Sun L; Wang H; Zhou W; Fang L; Li Q; Xie P
Virus Res; 2019 Oct; 271():197671. PubMed ID: 31330207
[TBL] [Abstract][Full Text] [Related]
3. Effect and molecular mechanism of mir-146a on proliferation of lung cancer cells by targeting and regulating MIF gene.
Wang WM; Liu JC
Asian Pac J Trop Med; 2016 Aug; 9(8):806-11. PubMed ID: 27569893
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of miR-146a increases cisplatin sensitivity of the non-small cell lung cancer A549 cell line by targeting JNK-2.
Pang L; Lu J; Huang J; Xu C; Li H; Yuan G; Cheng X; Chen J
Oncol Lett; 2017 Dec; 14(6):7745-7752. PubMed ID: 29344219
[TBL] [Abstract][Full Text] [Related]
5. miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1.
Zhang H; Hu B; Wang Z; Zhang F; Wei H; Li L
Cancer Chemother Pharmacol; 2017 Nov; 80(5):973-984. PubMed ID: 28956120
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J
Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-1 overexpression increases chemosensitivity of non-small cell lung cancer cells by inhibiting autophagy related 3-mediated autophagy.
Hua L; Zhu G; Wei J
Cell Biol Int; 2018 Sep; 42(9):1240-1249. PubMed ID: 29851226
[TBL] [Abstract][Full Text] [Related]
8. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.
Yuwen DL; Sheng BB; Liu J; Wenyu W; Shu YQ
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2650-2658. PubMed ID: 28678319
[TBL] [Abstract][Full Text] [Related]
9. miR-146a-5p Plays an Oncogenic Role in NSCLC via Suppression of TRAF6.
Liu X; Liu B; Li R; Wang F; Wang N; Zhang M; Bai Y; Wu J; Liu L; Han D; Li Z; Feng B; Zhou G; Wang S; Zeng L; Miao J; Yao Y; Liang B; Huang L; Wang Q; Wu Y
Front Cell Dev Biol; 2020; 8():847. PubMed ID: 33015045
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p/Wnt/β-catenin pathway.
Shi SL; Zhang ZH
Neoplasma; 2019 Sep; 66(5):756-765. PubMed ID: 31288529
[TBL] [Abstract][Full Text] [Related]
11. CircRNA CDR1as/miR-641/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC).
Zhao Y; Zheng R; Chen J; Ning D
Cancer Cell Int; 2020; 20():289. PubMed ID: 32655321
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Human Natural Killer Cell IFN-γ Production by MicroRNA-146a
Wang H; Zhang Y; Wu X; Wang Y; Cui H; Li X; Zhang J; Tun N; Peng Y; Yu J
Front Immunol; 2018; 9():293. PubMed ID: 29593706
[TBL] [Abstract][Full Text] [Related]
13. MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9.
Rao C; Miao X; Zhao G; Zhang C; Shen H; Dong C; Yang M
Biomed Pharmacother; 2019 Jun; 114():108662. PubMed ID: 30999114
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-146a-5p Downregulates the Expression of P-Glycoprotein in Rats with Lithium-Pilocarpine-Induced Status Epilepticus.
Deng X; Shao Y; Xie Y; Feng Y; Wu M; Wang M; Chen Y
Biol Pharm Bull; 2019; 42(5):744-750. PubMed ID: 31061316
[TBL] [Abstract][Full Text] [Related]
15. MiR-146a mediates TLR-4 signaling pathway to affect myocardial fibrosis in rat constrictive pericarditis model.
Xiao Y; Qiao W; Wang X; Sun L; Ren W
J Thorac Dis; 2021 Feb; 13(2):935-945. PubMed ID: 33717566
[TBL] [Abstract][Full Text] [Related]
16. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
Cai Y; Dong ZY; Wang JY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
[TBL] [Abstract][Full Text] [Related]
17. MiR-146a protects small intestine against ischemia/reperfusion injury by down-regulating TLR4/TRAF6/NF-κB pathway.
He X; Zheng Y; Liu S; Shi S; Liu Y; He Y; Zhang C; Zhou X
J Cell Physiol; 2018 Mar; 233(3):2476-2488. PubMed ID: 28771774
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in non-small cell lung cancer by targeting RUNX2.
Xie J; Yu F; Li D; Zhu X; Zhang X; Lv Z
Tumour Biol; 2016 Jan; 37(1):1197-204. PubMed ID: 26282001
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological effects of β-d-mannuronic acid (M2000) on miR-146a, IRAK1, TRAF6 and NF-κB gene expression, as target molecules in inflammatory reactions.
Mortazavi-Jahromi SS; Jamshidi MM; Farazmand A; Aghazadeh Z; Yousefi M; Mirshafiey A
Pharmacol Rep; 2017 Jun; 69(3):479-484. PubMed ID: 28324845
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-106b-5p regulates cisplatin chemosensitivity by targeting polycystic kidney disease-2 in non-small-cell lung cancer.
Yu S; Qin X; Chen T; Zhou L; Xu X; Feng J
Anticancer Drugs; 2017 Sep; 28(8):852-860. PubMed ID: 28723865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
